Search Results for "Nct00305227 Results"
Original Source: Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection
Recurrent urinary tract infections (RUTIS) continue to be a major health problem in women and are now complicated by increasing antibiotic resistance. New preventive approaches are needed. Because most women with RUTI lack the normal protective Lactobacillus (LB) in their vaginal flora, we hypothesized that restoration of LB would reduce RUTIS. In this trail, women with recent UTI are randomized to receive either LB or placebo vaginal capsules and are followed for side effects,...
Matching Channels
The Asymptomatic Patient With Abnormal Laboratory Test Results
Cholesteryl Ester Transfer Protein (CETP)
The Cholesteryl Ester Transfer Protein (CETP) facilitates the transfer of cholesterol from HDL to other lipoproteins including LDL, in exchange for triglycerides. The CETP mediated transfer of chole...
Sequencing platforms in diagnostic laboratories may aid both patient management by detecting resistance associated mutations, and public health measures, by determining phylogenetic relationships be...
Tricuspid regurgitation (tricuspid incompetence, tricuspid insufficiency) is leakage of blood backward through the tricuspid valve each time the right ventricle contracts.Tricuspid regurgitation is...
Macular degeneration in the elderly (AMD) is a major cause of blindness. Its prevalence increases to 30% in patients 75 to 85 years of age. AMD occurs in two forms: dry and wet AMD. Central geograph...
Matching News
Limited Results in Uterine Ca, but Tx Still Promising (CME/CE)
LOS ANGELES (MedPage Today) -- An investigational regimen for resected endometrial cancer missed its failure-free survival target but surpassed historical results in similar patient populations, resul...
Accuray Announces Results for Second Quarter Fiscal 2013
SUNNYVALE, Calif., Feb. 6, 2013 /- Accuray Incorporated, a radiation oncology company, (Nasdaq: ARAY ) today announced financial results for the second quarter of fiscal 2013 that ended December 31,...
Abbott Reports Initial Results From Aviator
NORTH CHICAGO (dpa-AFX) - Abbott (ABT) announced initial results from 'Aviator,' a phase 2b study of its interferon-free, investigational regimen for the treatment of hepatitis C. Initial results ...
UPDATE 2-Valeant sees Q2 results weaker than Q1
June 21 (Reuters) - Canada's Valeant Pharmaceuticals International Inc s aid on Thursday it expected its second-quarter results to be weaker than results in the first quarter, when it reported a net...
UPDATE 1-Valeant sees Q2 results weaker than Q1
June 21 (Reuters) - Canadian drugmaker Valeant Pharmaceuticals International Inc, s aid on Thursday second-quarter results will come in weaker than in the first quarter even as it expects fiscal 2012...
CAMBRIDGE, MA -- (Marketwire) -- 11/07/12 -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, today reported financial results for the three and nine mon...
Jazz Pharmaceuticals Announces Second Quarter 2012 Results
DUBLIN, Aug. 7, 2012 /- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced financial results for the second quarter ended June 30, 2012. These results include the first complete qua...
Kissei's Epoetin Results Up, Dialysis Scores Down
Kissei Pharmaceuticals announced its results for the second quarter Nov. 6.
Matching PubMed Articles
Statistical concepts related to negative clinical results.
It is a trend that clinical researchers overemphasize on hypothesis testing and the P value. However, P value has some limitations in the presentation of study results. Power is a tool for study desig...
